Earnings Feed
Start Free
Alamar Biosciences, Inc.·4

Apr 20, 8:33 PM ET

McAnear Justin J. 4

Research Summary

AI-generated summary

Updated

Alamar Biosciences (ALMR) CFO Justin McAnear Receives RSUs

What Happened

  • Justin J. McAnear, Chief Financial Officer of Alamar Biosciences (ALMR), was granted 37,220 restricted stock units (RSUs) on 2026-04-20 at $0.00 and the filing also reports a 163,358-share derivative award (acquired on 2026-04-16, $0) plus same-day “other” disposition and acquisition entries of 570,719 derivative shares on 2026-04-20 (all at $0.00). No cash changed hands in these reported entries; the $0 price indicates awards or internal reclassifications/conversions rather than open-market trades.

Key Details

  • Filing date: 2026-04-20; Period of Report: 2026-04-16. Filing appears timely.
  • Transactions and prices:
    • 2026-04-20: RSU grant — 37,220 shares @ $0.00 (acquired).
    • 2026-04-16: Derivative award — 163,358 shares @ $0.00 (acquired).
    • 2026-04-20: Other disposition — 570,719 derivative shares @ $0.00 (disposed).
    • 2026-04-20: Other acquisition — 570,719 derivative shares @ $0.00 (acquired).
  • Shares owned after these transactions: Not specified in the excerpt of the filing provided.
  • No cash proceeds reported; transactions are awards/conversions (derivative transactions), not open-market buys/sells.
  • Footnotes provided in the filing:
    • F1: RSUs — vest monthly from grant date, subject to continued service.
    • F2: Option vesting — 25% vests 4/16/2027, then 1/48th monthly thereafter (service condition).
    • F3: Class B common shares were reclassified to Common Stock immediately before the IPO.
    • F4: Option vesting — 25% vests 10/13/2026, then 1/48th monthly thereafter (service condition).

Context

  • These entries reflect compensation-related awards and derivative reclassifications/conversions rather than open-market purchases or sales. RSU grants and option awards are common executive compensation and typically vest over time; they do not by themselves indicate immediate buying or selling in the market.
  • The paired 570,719 “other” disposition and acquisition at $0 likely reflect an internal conversion or reclassification of derivative holdings (see F3) rather than a sale; the filing does not show cash proceeds.
  • For retail investors, awards (like RSUs) are less immediately informative about insider sentiment than open-market purchases, since they are compensation-related and subject to vesting and service conditions.